Methylmalonyl-CoA mutase (MCM) is an adenosylcobalamin-dependent enzyme that catalyses isomerization between methylmalonyl-CoA and succinyl-CoA (3-carboxypropionyl-CoA). Genetic deficiency of this enzyme in man causes an often fatal disorder of organic acid metabolism termed mut methylmalonicacidaemia. We report cloning of a mouse MCM cDNA and the characterization of its primary structure and biological function. Mouse MCM in fibroblasts and crude liver extracts exhibits activity and reaction kinetics similar to those of the human enzyme. The predicted amino acid sequence of mouse MCM exhibits 94 % identity with its human homologue and considerable identity with a prokaryotic MCM. Transfection of the mouse cDNA into cultured cells constitutes an active apoenzyme and can complement genetic deficiency of the apoenzyme in cells from patients with mut methylmalonicacidaemia. These results establish that mouse MCM is homologous to human MCM in structure and function and provides a basis for using the mouse as a model for studying this enzyme and its deficiency state.
INTRODUCTION
Methylmalonyl-CoA mutase (MCM, EC 5.4.99.2) is an adenosylcobalamin-dependent mitochondrial-matrix enzyme that catalyses isomerization between methylmalonyl-CoA and succinyl-CoA (3-carboxypropionyl-CoA). This enzyme has been characterized extensively in man, where this reaction is involved in the degradation of several amino acids, odd-chain fatty acids and cholesterol via propionyl-CoA to the tricarboxylic acid cycle [1] . Genetic deficiency of this enzyme in man causes a disorder of organic acid metabolism termed mut methylmalonicacidaemia (McKusick no. 251000) in which methylmalonate and abnormal metabolites of methylmalonate accumulate, leading to failure of many vital functions [1] .
MCM has different functions in other species. In ruminants MCM is essential for gluconeogenesis from propionate, a pathway that may account for 60-80 % of all glucose utilization [2, 3] .
In prokaryotes such as Propionibacterium shermanii [4] , Streptomyces erythreus [5] and Protaminobacter ruber [6] and eukaryotes such as Fasciola hepatica [7] and Spirometra mansonoides [7] , MCM catalyses the isomerization of succinylCoA to methylmalonyl-CoA during synthesis of propionate from tricarboxylic acid-cycle intermediates.
MCM has been purified from several species, including humans [8, 9] , Prop. shermanii [4, 10] , Strep. erythreus [5] and Ascaris lumbricoides [11] . We have recently reported cloning and sequencing of a human MCM cDNA [12, 13] . MCM from Prop. shermanii has also been cloned and sequenced [14] . We now report the biochemical characterization, cloning and sequencing of mouse MCM and the expression of recombinant mouse MCM by gene transfer. These results provide a fundamental description of mouse MCM and establish a foundation for using the mouse as a model for studying the structure and function of MCM and the consequences of its deficiency state in humans.
MATERIALS AND METHODS Assays of MCM activity in vitro and in live cultured cells
MCM was assayed in vitro by using the KMnO4/HCIO4 procedure [15, 16] . The assay reaction mixture contains 270,ug of extract, 100 mM-Tris/HCI buffer, pH 8.0, 300 /M-DLmethylmalonyl-CoA, 50000 d.p.m. of DL-[14C]methylmalonylCoA (56 mCi/mmol) and 36 ,M-adenosylcobalamin in a total volume of 250 gl and is incubated in the dark for 20 min at 30 'C. The reaction is stopped by addition of 50,ul of 2 M-HCIO4, incubation at 100 'C and 4 'C for 10 [19, 20] . Both strands of the mouse cDNA were sequenced by using subclones containing internal restriction fragments or terminal deletions introduced by ExollI digestion (Fig. 2c) [21] . Double-stranded dideoxy sequencing [22] was performed with the SP6 and T7 promoter primers or synthetic oligonucleotide primers listed in Table 1 . Sequence comparisons were made by using the on-line facilities of the Protein Identification Resource (National Biomedical Research Foundation, Washington, DC, U.S.A.).
Gene transfer and expression of mouse MCM
For expression in COS cells the mouse MCM cDNA was subcloned into the EcoRI site of the vector p91023B containing the adenovirus major late promoter [23] . COS cells [24] were transformed by Ca3(PO4)2 co-precipitation [25] , and protein extracts were harvested 48 h after transfection. Cantrol cells were transfected with an anti-sense clone or a vector expressing a dihydropteridine reductase cDNA [26] . For expression in primary human fibroblasts, the MCM cDNA was subcloned into the NotI site of the vector pNAssCMV [27] , which contains the cytomegalovirus immediate early promoter. This clone was introduced via electroporation [28] into a primary fibroblast cell line GM50 (NIGMS Mutant Cell Repository) derived from a patient with mut°methylmalonicacidaemia. The GM50 cell line exhibits no enzyme activity and expresses decreased amounts of (human) MCM mRNA [16] . Electroporation was performed with a Gene Pulser (Bio-Rad Laboratories) after preincubation of 0.3 ml of cells at a density of 3 x 106/ml for 5 min with 10-20,ug [30, 31] and was not assayed.
Nucleic acid sequence of mouse MCM cDNA The longest mouse cDNA clone, moMCM209 (Fig. 2b) , was sequenced completely in both directions as shown in Fig. 2(c) . The sequence contains 3245 base residues (Fig. 3) . A single long open reading frame begins with a Kozak consensus sequence (ACCAUG) [32] at position 47 and extends to a TAA termination codon at position 2291. The 5' untranslated region contains a prior ATG at position 37, which is interrupted by a TAA termination codon at position 58. A homologous reading frame exists in the human sequence [13] . The 3' untranslated region comprises 954 base residues and does not contain a poly(A) tail. A possible polyadenylation signal (AAATAAA) is present at base 3235, ten base residues before the end of the clone.
The nucleic acid sequence of mouse MCM exhibits profound similarity with human MCM. Comparison of the nucleic acid sequences of the mouse and human long open reading frames reveals 89 % identity. There is also considerable identity between the mouse and human sequences in the 5' untranslated region.
Predicted amino acid sequence of mouse MCM The long open reading frame codes for a protein of 748 amino acid residues and a molecular mass of 82 891 Da. The fidelity of the predicted reading frame is supported by identity with 105/113 residues (93 % of peptide sequence from human MCM reported previously (Fig. 3) as well as extensive identity with the predicted amino acid sequence of human MCM (Fig. 4) [13] . The predicted mouse and human MCM sequences share 700 identities out of 748 possible matches (940% identity) with the insertion of one break (Fig. 4 and Table 3 ). Mouse MCM preserves a strikingly asymmetrical amino acid composition, with proline, tryptophan and tyrosine residues disproportionally located in the N-terminal portion and cysteine residues located in the C-terminal portion.
There are few significant differences between the human and mouse apoenzymes. These include substitution of Cys-288 in mouse for Ser-288 in human and [33] , including arginine residues (three residues), hydrophobic and hydrophilic residues (e.g. serine, three residues; leucine, seven residues), and an arginine residue two residues from the proteinase-cleavage site [34] . This pattern of identity with human MCM predicts that endopeptidase cleavage will occur after the leucine residue at position 30 MetLeuArgAlaLysAanGlnLeuPheLeuLeuSerProHisTyrLeuLysGlnLeuAsnIleProSerAlaSer   5' ACACTGACCGTTCTCATCCTTTTGGGAGTATTCATGCTTCACCATGTTGAGAGCTAGATCACTTTGCTATCGCCCCATTACCTGAGCAGCTAACATTCCATCAGCTTC   10  20  30  40  50  60  70  80  90  100  110 As2D.gGlyAlaLysValIleAlaThrGlyPheAlaAspLeuGlyPheAspValAspIleGlyProLeuPheGlnThrProArgGluValAlaGlnHisAlaValAspAlaAspValHis 5' TGACAGGGGAGCCAGGTCATTGCTACAGGATTTGCTGATCTTGGTTGATGTGGACATAGGCCCTCTTTTTCAGACTCCCCGTGMGTGGCGCAGCATGCTGTGGATGCAGATGTCCA  1930  1940  1950  1960  1970  1980  1990  2000  2010  2020  2030  2040   AlaValGlyValSerThrLeuAlaAlaGlyHisLysThrLeuValProGluLeuIleLysGluLeuThrAlaLeuGlyArgProAspIleLeuValMetCysGlyGlyValIleProPro   5 ' TGCTGTGGGTGTCAGCACACTTGCTGCTGGTCATAAMACCCTCGTTCCTGAGCTTATCAAAGAACTCACCGCCCTGGGGCGGCCAGATATCCTTGTCATGTGTGGGGGCGTGATTCCACC  2050  2060  2070   2080  2090  2100  2110  2120  2130  2140  2150  2160   GlnAspTyrrGluPheLeuTyrGluValGlyValSerAsnValPheGlyProGlyThrArgIleProArgAlaAlaValGlnValLeuAspAspIleGluLysCysLeuAlaGluLysGln   S ' ACAGGATTATGAATTTCTGTATGAAGTTGGTGTTCCAACGTGTTTGGTCCTGGAACCCGGATTCCAAGAGCTGCTGTCCAAGTGCTTGATGATATTGAGAAGTGTTTGGCAGAGAAGCA  2170  2180  2190  2200  2210  2220  2230  2240  2250  2260  2270  2280 GlnSerVal*** 5 ' GCAGTCTGTGTACATCAGGATCTAGTTATGACTGAGCAGCAGTCTGTGTACATCTGGATCTAGTTATGACCGAGAGGTAGTGGTAAATCCGTTTCCGTCAGGTATCCCAG  2290  2300  2310  2320  2330  2340  2350  2360  2370  2380  2390  2400  5' CAGCTCTTAGATGCTTGCTTGGAACCTCACATTAA AGATTCTCTATAAATGTGCAGTCATGCC_TACACATATTTAAAGAATTGAGTTCCCTCTGA  2410  2420  2430  2440  2450  2460  2470  2480  2490  2500  2510  2520  5' AAATCATATACCAATATGTTTTAGTATATTATTCTAGAAAATAATGGTATACTATAGAATAGCTTACATTCTTATAATATTGACTTTTGTTGTTATCCTTTG   2530  2540  2550  2560  2570  2580  2590  2600  2610  2620  2630  2640  5' ACATGGGGTCTTACTATGTAGCACTGGTTGTCTTGCACTACTCTGTAGACAGTCTGGCCTCAAACTCACAGAGATCCACCTGCCTCTGCCTTCCTAGTACAGGGATTAAAGGTATGT  2650  2660  2670  2680  2690  2700  2710  2720  2730  2740  2750  2760   5' GCCTCCATGTCCTGCAAATTATTAAACTA _ AAT_ ATCCGATTCTTCCTTCATAGTGTTGATGTGTACTAGAAACTCAGTTCCTGTGTTATTT   2770  2780  2790  2800  2810  2820  2830  2840  2850  2860  2870  2880  5 ' ATAAATATGACATATCTTACAGAAATAGTGGAGGGTATATGGATGGATCCTCAGCCAGACCTACTATTGCTTCATAAAGTAGTGTATCACCCCCTGTACATGGATAG  2890  2900  2910  2920  2930  2940  2950  2960  2970  2980  2990  3000  5' GGGACATGGTAGATAGGCTTCCAGGATTGTGTCAGCTCCTCACATGGGATGATATTGTTATGTCAGGTTCAAACTCTGGAAAGATGTGTGTGACGCTCTCTTAAATGATGTTGAT  3010  3020  3030   3040  3050  3060  3070  3080  3090  3100  3110  3120  5' GGACAGATGCAT GCTATATGACAGTCTAA TCTATTACATA AGTAAATGA TTTTCAGATCTAGAAACACGCTGATCTGTATACACT CTTATTATA TA  3130  3140  3150  3160  3170  3180  3190  3200  3210  3220  3230 (Table 3) . Profound sequence similarity between human and Prop. shermanii MCM has been described previously [35] . Prop. shermanii MCM is a heterodimer composed of two polypeptides, an a-subunit (MUTB) with a molecular mass of 79 kDa, and a fl-subunit (MUTA) with a molecular mass of 67 kDa [10, 14] . The human MCM monomer exhibits 60 % identity with the MUTB gene and 22 % identity with the MUTA gene (Table 3 ) [35] . The mouse protein exhibits quantitatively sequence-similarity to the Prop. shermanii proteins, with 57 % identity with the MUTB gene and 26 % identity with the MUTA gene (Table 3) . Thus the structure-function determinants of the apoenzyme are tightly constrained, despite the fact that the eukaryotic and prokaryotic enzymes have different quaternary structure and catalyse opposite reactions under physiological conditions. The uniformly high degree of sequence conservation between these proteins makes it impossible to pinpoint specific regions that are of particular functional importance.
<-------PREDICTED MITOCHONDRIAL TARGETING SEQUENCE -----------------------

--------------X-------PREDICTED TERMINUS OF NATURE
Expression of MCM activity from the mouse MCM cDNA
In order to demonstrate the authenticity and function of the mouse cDNA clone, the cDNA was introduced into COS cells by using the p91023B expression vector. COS cells exhibit endogenous MCM activity that was not affected by transformation with anti-sense MCM or a dihydropteridine reductase expression vector (Table 4) . MCM apoenzyme activity was quantitatively increased by transfection with mouse MCM in the sense orientation, indicating that the moMCM209 clone encodes an active enzyme. The endogenous MCM activity in COS cells precludes more detailed analysis of the recombinant gene product.
In order to have a better system in which to study the MCM cDNA and to demonstrate that the mouse MCM cDNA was congruous with the locus defective in mut forms of MMA, the mouse MCM cDNA was introduced into a human mut°fibroblast line (GM50) by using the vector pCMV-moMCM. GM50 cells electroporated with the pCMV-moMCM sense construct showed an increase in MCM activity, as measured by the [14C]propionate uptake assay, to essentially normal levels (Fig. 5) . These data confirm the authenticity of the mouse MCM cDNA clone and confirm somatic-cell complementation data that demonstrated that mut MMA arises from defects in the MCM apoenzyme. shown. Basal activity in the absence of electroporation is also shown (-).
Conclusion
Several lines of investigation are converging on a description of structure-function determinants and biological significance of MCM. The cloning and expression of human, Prop. shermanii, and now mouse MCM have provided the primary structure of MCM and a system for studying mutations. Other work has identified several mutations that give rise to variant phenotypes of mut methylmalonicacidaemia, including complete MCM deficiency [36] , failure of post-translational processing of MCM [37] 
